Dube Eric M
Related Filers (2)
Other (4)
144
Thursday, 2/1/2024
Filing for proposed sale of securities under Rule 144
144
Thursday, 2/1/2024
Filing for proposed sale of securities under Rule 144
144
Tuesday, 1/23/2024
Filing for proposed sale of securities under Rule 144
144
Tuesday, 9/5/2023
Filing for proposed sale of securities under Rule 144
Ownership (28)
4
Friday, 2/2/2024
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/25/2024
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/5/2023
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/8/2023
Reneo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/2/2023
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/26/2023
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/6/2023
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/3/2022
Reneo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/11/2022
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/2/2022
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/26/2022
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/6/2022
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/17/2021
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/3/2021
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 4/8/2021
Reneo Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 2/9/2021
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/5/2021
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/3/2021
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/2/2021
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4/A
Thursday, 1/28/2021
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/25/2021
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/7/2021
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/22/2020
Retrophin, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/31/2020
Retrophin, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/8/2020
Retrophin, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/10/2019
Retrophin, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 1/8/2019
Retrophin, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 1/8/2019
Retrophin, Inc.: Statement of changes in beneficial ownership of securities